Search Results - "Callizot, N"
-
1
AZP2006, a new promising treatment for Alzheimer’s and related diseases
Published in Scientific reports (19-08-2021)“…Progranulin (PGRN) is a protein with multiple functions including the regulation of neuroinflammation, neuronal survival, neurite and synapsis growth. Although…”
Get full text
Journal Article -
2
Huperzia serrata Extract 'NSP01' With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols
Published in Frontiers in pharmacology (30-08-2021)“…(Thunb.) Trevis is widely used in traditional asiatic medicine to treat many central disorders including, schizophrenia, cognitive dysfunction, and dementia…”
Get full text
Journal Article -
3
Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling
Published in Cell death & disease (01-01-2015)“…Pancreatic ductal adenocarcinoma (PDA) is a critical health issue in the field of cancer, with few therapeutic options. Evidence supports an implication of the…”
Get full text
Journal Article -
4
The frissonnant Mutant Mouse, a Model of Dopamino-Sensitive, Inherited Motor Syndrome
Published in Neurobiology of disease (01-06-2001)“…The frissonnant (fri) mutation is an autosomic recessive mutation which spontaneously appeared in the stock of C3H mice. fri mutant mice have locomotor…”
Get full text
Journal Article -
5
Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy
Published in Human molecular genetics (01-12-2004)“…X-linked adrenoleukodystrophy (X-ALD) is a severe neurodegenerative disease caused by loss of function of the peroxisomal transporter ABCD1 (ALD), which…”
Get full text
Journal Article -
6
Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy
Published in Human molecular genetics (01-03-2002)“…Adrenomyeloneuropathy (AMN) and cerebral childhood adrenoleukodystrophy (CCALD) are the main phenotypic variants of an X-linked inherited metabolic disorder…”
Get full text
Journal Article -
7
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury
Published in Journal of neurochemistry (01-10-2005)“…Excessive glutamate release is associated with neuronal damage. A new strategy for the treatment of neuronal injury involves inhibition of the neuropeptidase…”
Get full text
Journal Article -
8
204 ANTINOCICEPTIVE EFFECTS OF LACOSAMIDE IN THE STREPTOZOTOCIN RAT MODEL OF DIABETIC NEUROPATHIC PAIN
Published in European journal of pain (01-09-2006)Get full text
Journal Article -
9
Interleukin-6 attenuates the development of experimental diabetes-related neuropathy
Published in Neuropathology (01-02-2006)“…Neuropathy is the most severe and the least understood complication of diabetes. We investigated the potential neuroprotective effect of IL‐6 therapy in an…”
Get full text
Journal Article -
10
Pyridoxine-Induced Neuropathy in Rats: A Sensory Neuropathy That Responds to 4-Methylcatechol
Published in Neurobiology of disease (01-08-2001)“…Sensory neuropathies are frequently associated with diabetes or with antimitotic treatments in humans suffering from cancer, and are in this case the most…”
Get full text
Journal Article -
11
Workshop 5: NAAG and NAALADase: Functional Properties in the Central and Peripheral Nervous System. Naaladase (GCPII) knockout mice are less susceptible to neuropathy and stroke
Published in Journal of neurochemistry (01-06-2002)“…Glutamate carboxypeptidase II (GCPII, also known as N‐acetylated‐alpha‐linked acidic dipeptidase or NAALADase) knockout (KO) mice were generated by inserting a…”
Get full text
Journal Article